Kim Smith-Whitley, MD

Areas of Expertise: Bone marrow failure, General hematology, Sickle cell disease
Locations: Main Campus
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

  • Background

    Dr. Smith-Whitley is the Medical Director of the Sickle Cell Clinical Program, the Clinical Director of the Division of Hematology, an Associate Professor of Pediatrics and she holds the Elias Schwartz, MD, Endowed Chair in Hematology.

    Her clinical and research focus is on sickle cell survivorship: predicting and preventing long-term, chronic, and life-threatening complications of the disease. She initiated two innovative programs at CHOP:

    • A short-stay Hematology Acute Care Unit
    • The Blue Tie Tag program to recruit blood donors for pediatric transfusions

    She received the 2010 Blockley-Osler Award for excellence in teaching clinical medicine at the bedside.

  • Education and Training

    Medical School

    George Washington University School of Medicine, Washington, DC


    Children's National Medical Center, Washington, DC


    The Children's Hospital of Philadelphia, Philadelphia, Pa.

    Board Certification

    American Board of Pediatrics
    American Board of Pediatrics/Hematology-Oncology

  • Titles and Academic Titles

    Medical Director, Sickle Cell Clinical Program

    Clinical Director, Division of Hematology

    Attending physician

  • Conditions Treated
  • Departments and Services
  • Publications



    Bride KL, Vincent T, Smith-Whitley K, Lambert MP, Bleesing JJ, Seif AE, Manno CS, Casper J, Grupp SA, Teachey DT. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood. 2016 Jan 7;127(1):17-28.